Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease

was shown to induce hemodynamic changes in mouse, a known on-target effect of EP4 agonists in systemic circulation. High-throughput mutagenesis studies and computational modeling indicate that this series of agonists binds orthosterically to the PGE2 site in the EP4 receptor despite structural differentiation from prostanoids.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-04-03
DOI
https://doi.org/10.1021/acs.jmedchem.6c00130
Primary Topic
Inflammatory mediators and NSAID effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease

R. M. Borzilleri, Laura E. Armstrong, Jenny Xie, Mary T. Obermeier et al.
Journal of Medicinal Chemistry
Inflammatory mediators and NSAID effects
article

Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease

R. M. Borzilleri, Laura E. Armstrong, Jenny Xie, Mary T. Obermeier, David Marcoux, Purnima Khandelwal, Heidi L. Perez, Sunita Dewnani, Yazh Muthukumar, Steven A. Spronk, K. Ghosh, Brian J. Arey, Trevor C. Sherwood, Victor R. Guarino, Alaric J. Dyckman, William J. Pitts, Samuel W. Gerritz, Amy C. Hart, Chi Shing Sum, Mojgan Abousleiman, Chandra Sekhar Bokka, Tamara I. King, Carolyn D. Dzierba, Li Li, Fei Yu, Patrick J. Shaw, Brian Anderson, Hai-yun Xiao, Mary Struthers, M M Prack, Carol Krause, Tao Wang, Julia Li, Trevor Vernon, Ramakrishna Chandran, Margarita Garcia-Calvo, Derek Holmes, Riyaz Khan
article en

Abstract

was shown to induce hemodynamic changes in mouse, a known on-target effect of EP4 agonists in systemic circulation. High-throughput mutagenesis studies and computational modeling indicate that this series of agonists binds orthosterically to the PGE2 site in the EP4 receptor despite structural differentiation from prostanoids.

Journal of Medicinal ChemistryVol. 69(8)
Bristol-Myers Squibb (Germany) (DE), Bristol-Myers Squibb (India) (IN)
Good health and well-being
Openalex Percentile: Top 30%
Inflammatory mediators and NSAID effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.